Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION: Adjuvant Chemotherapy in Older Women
NCT00516425Phase 3Unknown
- Sponsor
- Charing Cross Hospital
- Start
- Jan 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, epirubicin, cyclophosphamide in breast cancer, sponsored by Charing Cross Hospital. Status: unknown.
02
Drugs
doxorubicinepirubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00516425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516425.